NRXP
NRX Pharmaceuticals (NRXP)
$50
About NRX Pharmaceuticals (NRXP)
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
Details
Daily high
$1.55
Daily low
$1.46
Price at open
$1.55
52 Week High
$7.33
52 Week Low
$1.10
Market cap
18.1M
Dividend yield
0.00%
Volume
380,130
Avg. volume
329,603
P/E ratio
-.70
NRX Pharmaceuticals News
Details
Daily high
$1.55
Daily low
$1.46
Price at open
$1.55
52 Week High
$7.33
52 Week Low
$1.10
Market cap
18.1M
Dividend yield
0.00%
Volume
380,130
Avg. volume
329,603
P/E ratio
-.70